Mariotto, Sara
 Distribuzione geografica
Continente #
NA - Nord America 7.060
EU - Europa 6.186
AS - Asia 5.234
SA - Sud America 833
AF - Africa 196
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 19.542
Nazione #
US - Stati Uniti d'America 6.871
RU - Federazione Russa 2.945
SG - Singapore 2.114
CN - Cina 1.373
IT - Italia 818
BR - Brasile 667
GB - Regno Unito 622
VN - Vietnam 517
HK - Hong Kong 438
DE - Germania 333
FR - Francia 327
SE - Svezia 306
IE - Irlanda 305
KR - Corea 173
FI - Finlandia 167
BD - Bangladesh 139
CA - Canada 102
IN - India 94
AR - Argentina 71
JP - Giappone 63
ID - Indonesia 61
NL - Olanda 51
PL - Polonia 48
UA - Ucraina 48
ZA - Sudafrica 47
ES - Italia 46
MX - Messico 41
BE - Belgio 39
TR - Turchia 37
IQ - Iraq 36
AT - Austria 32
TG - Togo 29
AU - Australia 27
NG - Nigeria 27
BJ - Benin 25
PK - Pakistan 25
IR - Iran 23
EC - Ecuador 22
CL - Cile 19
MA - Marocco 19
LT - Lituania 18
SA - Arabia Saudita 17
UZ - Uzbekistan 17
VE - Venezuela 16
AE - Emirati Arabi Uniti 15
JM - Giamaica 15
CO - Colombia 14
EG - Egitto 11
PH - Filippine 11
KE - Kenya 10
CH - Svizzera 9
JO - Giordania 9
PY - Paraguay 9
IL - Israele 8
RO - Romania 8
TN - Tunisia 8
PT - Portogallo 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
KZ - Kazakistan 6
NP - Nepal 6
UY - Uruguay 6
CR - Costa Rica 5
HR - Croazia 5
LB - Libano 5
OM - Oman 5
PE - Perù 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
AL - Albania 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
GR - Grecia 4
LU - Lussemburgo 4
ML - Mali 4
PA - Panama 4
PS - Palestinian Territory 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
DK - Danimarca 3
DZ - Algeria 3
HU - Ungheria 3
KG - Kirghizistan 3
KW - Kuwait 3
LK - Sri Lanka 3
LV - Lettonia 3
MY - Malesia 3
RS - Serbia 3
SV - El Salvador 3
TH - Thailandia 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
CI - Costa d'Avorio 2
GE - Georgia 2
HN - Honduras 2
MD - Moldavia 2
NI - Nicaragua 2
Totale 19.506
Città #
Ashburn 1.098
Singapore 1.084
Moscow 1.022
San Jose 780
Dallas 710
Chandler 690
Hong Kong 434
Southend 414
Verona 328
Beijing 297
Dublin 291
The Dalles 229
New York 192
Council Bluffs 172
Ho Chi Minh City 171
Los Angeles 171
Woodbridge 157
Jacksonville 133
Ann Arbor 111
Hanoi 108
Lawrence 98
Princeton 98
Wilmington 85
Helsinki 79
Munich 73
Jinan 71
Houston 70
Dearborn 66
Buffalo 65
Redondo Beach 62
São Paulo 62
Santa Clara 60
London 56
Shenyang 55
Nanjing 53
Redmond 53
Sindelfingen 52
Milan 50
Tokyo 48
Orem 47
Warsaw 45
Columbus 44
Hebei 43
Tianjin 42
Jakarta 41
Montreal 40
Washington 40
Dong Ket 36
Seattle 36
Brooklyn 35
Chicago 35
Brussels 34
Guangzhou 34
Phoenix 34
Seoul 33
Lappeenranta 31
Boardman 30
Bologna 29
Frankfurt am Main 29
Lomé 29
Nuremberg 29
Denver 28
Changsha 27
Ningbo 27
Turku 26
Abuja 25
Cotonou 25
Johannesburg 24
Rome 24
Zhengzhou 24
Amsterdam 23
Hangzhou 23
Toronto 23
Adelaide 22
Atlanta 22
Belo Horizonte 22
Chennai 22
Nanchang 22
Falls Church 21
Rio de Janeiro 21
Taiyuan 21
Haiphong 20
Poplar 20
Da Nang 19
Mexico City 19
Paris 19
Haikou 18
Kent 18
Redwood City 16
Stockholm 16
Taizhou 16
Vienna 16
Baghdad 15
Boston 15
Norwalk 15
Florence 14
Mumbai 14
Bloomsbury 13
Falkenstein 13
Hải Dương 13
Totale 11.425
Nome #
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 261
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian Consensus Conference on Pain in Neurorehabilitation 247
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management 245
Cyclooxygenase 2, toll-like receptor 4 and interleukin 1beta mRNA expression in atherosclerotic plaques of type 2 diabetic patients. 236
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 233
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 227
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 214
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 214
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 212
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 210
Brentuximab vedotin: axonal microtubule's Apollyon 209
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 207
Time for a Consensus Conference on pain in neurorehabilitation 207
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder 206
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 201
Neurosyphilis manifesting with rapidly progressive dementia: report of three cases. 196
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 196
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 190
Nervous system: subclinical target of SARS-CoV-2 infection 186
Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy 186
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report. 185
Acute cervical longitudinally extensive transverse myelitis in a child with Lipopolysaccharide-Responsive-Beige-Like-Anchor-Protein (LRBA) deficiency: a new complication of a rare disease 178
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 177
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 177
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 175
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 173
Sural nerve biopsy: current role and comparison with serum neurofilament light chain levels 172
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 170
Antibodies to MOG in CSF only: pathological findings support the diagnostic value 170
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series 170
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 169
MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome 167
The original histological slides of Camillo Golgi and his discoveries on neuronal structure 163
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 158
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 157
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies 157
Hypothalamic-Bulbar MRI hyperintensity in Anti-IgLON5 disease with serum-restricted antibodies: a case report and systematic review of literature 156
Anti-MOG-associated demyelinating disorders: two sides of the same coin 155
Application of the international criteria for optic neuritis in the Acute Optic Neuritis Network 154
Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings 153
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 149
GABA(A) receptor autoimmunity after alemtuzumab treatment for multiple sclerosis 149
Gender disparity in editorial boards of journals in neurology 149
Autoimmune movement disorders complicating treatment with immune checkpoint inhibitors 148
Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review 148
Oligoclonal bands: clinical utility and interpretation cues 148
Cognitive Profile in Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparative Study With Multiple Sclerosis 147
Clinical Neuropathology image 1-2018: Golgi silver staining, the black reaction 145
Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study 144
Is there a correlation between MOGAD and SARS-CoV-2 infection? 143
Autoimmune encephalitis misdiagnosis and mimics 142
Inter-center agreement in the interpretation of oligoclonal bands 141
A score that predicts aquaporin-4-IgG positivity in patients with longitudinally extensive transverse myelitis 139
HCV-related nervous system disorders. 138
Neurofilament light chain levels in patients with antibodies to myelin oligodendrocyte glycoprotein (MOG-Abs) 138
The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis 136
Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorder through a data-driven approach 135
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 134
Brain stimulation as a therapeutic tool in Amyotrophic Lateral Sclerosis: current status and interaction with mechanisms of altered cortical excitability 133
GFAP as a marker of astrocytic damage correlated with medication overuse in migraine 131
Brain Volume Measures in Adults with MOG-Antibody-Associated Disease: A Longitudinal Multicenter Study 129
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 129
Mechanisms of nerve damage in neuropathies associated with hematological diseases: lesson from nerve biopsies 128
Cerebrospinal fluid analysis and the determination of oligoclonal bands 127
A novel cell-based immunofluorescence assay for the detection of autoantibodies to myelin-associated glycoprotein 127
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder 126
Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease 126
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD) 126
Peripheral neuropathy and central nervous system involvement in cryoglobulinenia. 125
Review of West Nile virus epidemiology in Italy and report of a case of West Nile virus encephalitis. 124
Autoimmune encephalitis: a retrospective monocentric experience 124
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 123
SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study 122
l-dopa-induced off: functional overlay in Parkinson disease 122
Infectious neuropathies 122
Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis 122
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD, a literature review 121
Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens 120
Cerebellar involvement associated with immune checkpoint inhibitors: a systematic review 119
Investigating the association between neoplasms and MOG antibody-associated disease 116
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder 115
Serum neurofilament to Magnetic Resonance Imaging lesion area ratio differentiates spinal cord infarction from acute myelitis 115
HCV-related central and peripheral nervous system demyelinating disorders. 113
Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations 113
Exposure to TNF inhibitors is rare at MOGAD presentation 113
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 113
Diagnostics of dysimmune peripheral neuropathies 112
Peripheral neuropathies during the COVID-19 pandemic: is there a relation? 111
NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders 110
Peripheral neuropathy and MOG-IgG: a clinical and neuropathological retrospective study 109
Sporadic Creutzfeldt-Jakob disease: prion pathology in medulla oblongata-possible routes of infection and host susceptibility. 109
Diagnostics of anti-MAG antibody polyneuropathy 109
Lymphomatosis cerebri and anti-NMDAR antibodies: A unique constellation 109
Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, Italy 109
Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status 108
Brentuximab vedotin-induced peripheral neuropathy: looking at microtubules 108
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 107
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors: Focus on Chronic Toxicities 106
Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers 105
Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders 105
Totale 15.133
Categoria #
all - tutte 72.922
article - articoli 71.194
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 462
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.266
Totale 145.844


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022864 57 266 2 119 19 32 15 37 32 37 71 177
2022/20231.939 115 188 160 343 141 470 25 131 232 33 63 38
2023/20241.279 47 82 137 136 112 304 56 76 21 71 167 70
2024/20253.180 149 198 120 493 155 117 188 199 534 245 258 524
2025/202610.421 647 675 639 1.612 2.775 652 920 658 767 549 220 307
2026/2027106 106 0 0 0 0 0 0 0 0 0 0 0
Totale 19.835